Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
Conditions: Pancreatic Cancer Interventions: Drug: nimotuzumab; Drug: AG chemotherapy Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Liver | Pancreas | Pancreatic Cancer | Research | Study | Urology & Nephrology